The top medtech stories of early 2017

[Image courtesy of the White House]

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry.

But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, diabetes treatment advances including promising study results for Insulet’s Omnipod Horizon hybrid closed-loop system, and much more.

Here are the top medical device stories of early 2017.